Free Trial
→ Trump Knows Exactly What He's Doing (From Brownstone Research) (Ad)
LON:4BB

4basebio 5/27/2025 Earnings Report

4basebio logo
GBX 1,070.80 -39.20 (-3.53%)
As of 05/29/2025 08:38 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 0.94
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Date
5/27/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4basebio Plc - Final Results and Notice of AGM
May 27 at 6:11 AM | uk.finance.yahoo.com
4basebio doubles DNA sales revenue, secures key partnerships
May 27 at 6:11 AM | za.investing.com
Trump Knows Exactly What He's Doing
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
May 30, 2025 | Brownstone Research (Ad)
4basebio Plc - Director Dealing
April 4, 2025 | uk.finance.yahoo.com
4basebio CEO Increases Stake with Share Purchase
April 4, 2025 | tipranks.com
4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA
April 4, 2025 | msn.com
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles